awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q53841619-814910DA-7F88-45B6-A7DD-0E30680CB11C
Q53841619-814910DA-7F88-45B6-A7DD-0E30680CB11C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53841619-814910DA-7F88-45B6-A7DD-0E30680CB11C
Alpha-1 antitrypsin treatment of new-onset type 1 diabetes: An open-label, phase I clinical trial (RETAIN) to assess safety and pharmacokinetics.
P2860
Q53841619-814910DA-7F88-45B6-A7DD-0E30680CB11C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53841619-814910DA-7F88-45B6-A7DD-0E30680CB11C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
04c79d003dc59166b57e9483bde5992794d5fd41
P2860
Alpha-1 antitrypsin therapy is safe and well tolerated in children and adolescents with recent onset type 1 diabetes mellitus